December 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreDecember 26, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 02, 2026
Market insights predict the global parenteral antibiotics industry will increase from USD 25.3 billion in 2025 to USD 38.7 billion by 2035, achieving a CAGR of 4.34%. The huge preference for parenteral antibiotics is driven by malabsorption issues, lack of oral formulations, and failed oral therapy....
January 02, 2026
The GLP-1 receptor agonist market size is calculated at $62.86 bn in 2025 is to hit $315.33 bn by 2035. GLP-1 receptor agonists are peptide drugs that mimic the GLP-1 hormone to lower blood glucose and aid weight loss. With rising diabetes and obesity rates, the market is growing. Recent developments include Eli Lilly's Zepbound, Novo Nordisk's par...
January 02, 2026
Market insights predict the global rheumatoid arthritis drugs industry will increase from USD 18.69 billion in 2024 to USD 29.31 billion by 2034, achieving a CAGR of 4.6%. Rheumatoid arthritis (RA) drugs help reduce pain, swelling, and joint damage by controlling the immune system’s overactive response. Treatments include NSAIDs for pain, ste...
December 31, 2025
Based on market forecasts, the aesthetic neurotoxin market was valued at USD 6.15 billion in 2026 and is projected to reach approximately USD 11.54 billion by 2035, expanding at a CAGR of 7.24% during 2026–2035. This report provides comprehensive coverage of market segmentation by product type, application, treatment area, and end-user/provid...
December 31, 2025
Market insights predict, the wound closure market was valued at USD 15.22 billion in 2025 and is projected to reach USD 16.3 billion in 2026, expanding to USD 30.35 billion by 2035 at a CAGR of 7.15% during 2026–2035. The report provides in-depth analysis across product types, wound types, material types, applications, end-users, and closure ...
December 31, 2025
According to market projections, the global hyperthermia cancer treatment market, valued at USD 210.54 million in 2025, is anticipated to reach USD 380.63 million by 2035, growing at a CAGR of 6.1% over the next decade. The rising incidences of cancer, growing research & development, and increasing investments drive the market....
December 31, 2025
Market insights predict, the epinephrine industry is expected to grow from USD 3.37 billion in 2025 to USD 7.51 billion by 2035, driven by a CAGR of 8.34%. The increasing incidences of acute disorders like cardiovascular disorders, asthma, and allergic reactions; advanced healthcare infrastructure; and growing research & development activities ...
December 31, 2025
The U.S. home infusion therapy industry is projected to rise from USD 19.56 billion in 2025 to USD 36.88 billion by 2035, reflecting a CAGR of 7.3% over the next decade. Home infusion therapy in the U.S. lets patients receive medications like antibiotics, pain management, or nutrition through an IV at home instead of a hospital. It’s a conven...
December 31, 2025
According to market projections, the huntington's disease treatment sector is expected to grow from USD 716.76 million in 2025 to USD 1519.02 million by 2035, reflecting a CAGR of 7.8%. Huntington's disease treatment focuses on managing symptoms, as there's no cure yet. Medications help control movement issues and mood changes, while therapy suppor...
December 30, 2025
According to forecasts, the global hemorrhoids treatment market will grow from USD 1.21 billion in 2025 to USD 2.18 billion by 2035, with an expected CAGR of 6.05%. The rising incidence of hemorrhoids and the increasing minimally invasive procedures drive the market. North America dominated the global market due to a robust healthcare infrastructur...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com